Literature DB >> 1767814

Adenosine reduces the Ca2+ transients of isoproterenol-stimulated rat ventricular myocytes.

R A Fenton1, E D Moore, F S Fay, J G Dobson.   

Abstract

Adenosine in the heart attenuates the contractile and metabolic effects of beta-adrenergic stimulation. The effect of adenosine on changes in intracellular Ca2+ concentration [( Ca2+]i) elicited with electrical stimulation was studied in rat ventricular myocytes in the absence and presence of isoproterenol (ISO). Fura-2 was utilized as a Ca2+ indicator. Autofluorescence was determined, and in vivo calibration was conducted, for each myocyte. Phenylisopropyladenosine (PIA; 10(-7) M; 5 min), an adenosine A1 receptor agonist, had no effect on the Ca2+ transient magnitude (TM) or the rate of Ca2+ transient decline determined at 150 nM Ca2+(i) (RD150). ISO (10(-8) M; 1 min) in the continued presence of PIA resulted in a 16% increase in the TM, but no change in the RD150. Inhibiting the PIA with 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 10(-7) M; 3 min) in the continued presence of ISO plus PIA resulted in a further 51% increase in the TM and a 57% increase in the RD150. In PIA-treated myocytes, ISO-induced spontaneous high-frequency Ca2+ transients occasionally were observed after the inhibition of PIA by DPCPX. The results of this study suggest that adenosine attenuates myocardial contractile responses to beta-adrenergic stimulation, in part, by reducing the beta-adrenergic-induced changes in the Ca2+ transients occurring in the contracting ventricular myocyte.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1767814     DOI: 10.1152/ajpcell.1991.261.6.C1107

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Differential effects of adenosine A2a and A2b receptors on cardiac contractility.

Authors:  P Charukeshi Chandrasekera; Victoria J McIntosh; Frank X Cao; Robert D Lasley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-08       Impact factor: 4.733

Review 2.  The exercising heart at altitude.

Authors:  José A L Calbet; Paul Robach; Carsten Lundby
Journal:  Cell Mol Life Sci       Date:  2009-10-07       Impact factor: 9.261

3.  Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling.

Authors:  P Charukeshi Chandrasekera; Tina C Wan; Elizabeth T Gizewski; John A Auchampach; Robert D Lasley
Journal:  Cell Signal       Date:  2013-01-03       Impact factor: 4.315

4.  Myocardial adenosine A(1)-receptor-mediated adenoprotection involves phospholipase C, PKC-epsilon, and p38 MAPK, but not HSP27.

Authors:  Richard A Fenton; Lynne G Shea; Cecilia Doddi; James G Dobson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

5.  Crosstalk between adenosine A1 and β1-adrenergic receptors regulates translocation of PKCε in isolated rat cardiomyocytes.

Authors:  Satoshi Komatsu; James G Dobson; Mitsuo Ikebe; Lynne G Shea; Richard A Fenton
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

Review 6.  Adenosine receptors and membrane microdomains.

Authors:  Robert D Lasley
Journal:  Biochim Biophys Acta       Date:  2010-10-01

7.  Functional studies in atrium overexpressing A1-adenosine receptors.

Authors:  J Neumann; U Vahlensieck; P Boknik; B Linck; H Lüss; F U Müller; G P Matherne; W Schmitz
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

8.  Adenosine A2A and beta-adrenergic calcium transient and contractile responses in rat ventricular myocytes.

Authors:  James G Dobson; Lynne G Shea; Richard A Fenton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-10       Impact factor: 4.733

9.  Adenoprotection of the heart involves phospholipase C-induced activation and translocation of PKC-epsilon to RACK2 in adult rat and mouse.

Authors:  Richard A Fenton; Satoshi Komatsu; Mitsuo Ikebe; Lynne G Shea; James G Dobson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-12       Impact factor: 4.733

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.